JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
IKT - Inhibikase Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary IKT Stock
Financials
Financials IKT Stock
Loading...
Loading...
Income Statement
Income Statement IKT Stock
Balance Sheet
Balance Sheet IKT Stock
Cash Flow Statement
Cash Flow Statement IKT Stock
Loading...
Loading...
IKT Financials - Inhibikase Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Inhibikase Therapeutics, Inc. (IKT)
Financials
Financials of IKT
Loading...
Loading...
Loading...
Loading...
Revenue
N/A
Operating Income
$-51.974283M
Net Income
$-48.259189M
Share Count (Basic)
98.31019M
Operating Cash Flow
$-27.786464M
Free Cash Flow
$-27.799863M
Cash And Short-Term Equivalents
$218.34382M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
1M
2M
3M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
Q1 FY25
Q2 FY25
Q3 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-50M
-40M
-30M
-20M
-10M
Annual
Quarterly
Margins
Gross
Operating
Net
-15000%
-10000%
-5000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-16M
-14M
-12M
-10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
No data available